Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7421 p415
7 October 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Government needs to ensure commissioning is fair

Central government needs to send out clear signals that a level playing field must be established for commissioning primary care services, the National Pharmacy Association has urged.

In its written response to the All-Party Pharmacy Group’s inquiry into the future of pharmacy (PJ, 24 June, p739), the NPA warns: “The potential for pharmacy-based services (and the benefit the public will gain from them) will not be realised unless pharmacists are treated equitably by commissioners in relation to other would-be service providers.”

Yet current evidence suggests this is frequently not the case, it says. “Transparent governance arrangements must be put in place to ensure a level playing field among providers and a clear message should come from central government that PCTs will be judged on this matter.”

The NPA also emphasises that there is a window of time during which NHS services will be redesigned to achieve the “Our health, our care, our say” White Paper aim of shifting more care into community settings. “Pharmacy must establish a sustainable place in the new care pathways before this window closes, so there is an urgent need to expand,” it says.

However, the need to make the best use of this time should not fluster community pharmacists, the response says. “It is important that pharmacists do not feel panicked into picking up roles that are not sustainable and that do not build on the strengths that differentiate pharmacy from other providers.”

Nonetheless, the NPA argues, dispensing medicines should remain the central service in community pharmacy. “The accurate and timely supply of prescribed medicines is the backbone of the community pharmacy service. The dispensing process provides the opportunity to build close relationships with service users — to the great benefit of all concerned — and also the platform on which to set other services.”

Back to Top


©The Pharmaceutical Journal